We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 7,514

Recent Patent Office decision provides further clarity in patentability of nucleic acids in Australia
  • Fisher Adams Kelly Callinans
  • Australia
  • December 9 2016

As has been widely reported, including in our previous articles such as this, the patentability or otherwise of isolated nucleic acids has been a


A comparative study of strategies for patenting human therapeutics in the Asia Pacific Region: IP In Depth
  • Fisher Adams Kelly Callinans
  • Asia-Pacific, Australia
  • December 9 2016

In the last century, innovations in the life sciences have allowed for treatment and prevention of numerous diseases and disorders, enabling higher


The Supreme Court Hears Oral Argument On Infringement Liability For U.S. Exporters Under
  • Fitzpatrick, Cella, Harper & Scinto
  • USA
  • December 7 2016

On December 6, 2016, the Supreme Court heard oral argument on the interpretation and application of 35 U.S.C. 271(f)(1) in Life Technologies Corp


We need to talkabout Pharmaceuticals and Standard Essential Patents
  • Bristows LLP
  • United Kingdom
  • December 7 2016

At the end of last month, Commissioner Vestager gave a speech at the Chillin’ Competition Conference. The focus: how competition law can protect


Rapid Litigation Management v. Cellzdirect
  • Workman Nydegger
  • USA
  • December 7 2016

Recently, the Federal Circuit held that a method for preparing hepatocytes was patent-eligible concept in the case Rapid Litigation Management v


Longer Monopolies and Single Legal Proceedings vs. Generics - the Gift of CETA to Canadian Drug Patentees
  • Aird & Berlis LLP
  • Canada
  • December 6 2016

Canadian pharmaceutical patent owners can expect two substantive changes in the next year following implementation of the Canada-European


Patents: insufficiency and infringement
  • Bird & Bird
  • United Kingdom
  • December 6 2016

The Court of Appeal has held that a patent with claims in Swiss form directed to a second medical use was invalid for insufficiency and also commented


Insights: Patent infringement action against two manufacturers seeking to launch a new pain relief patch
  • Boult Wade Tennant
  • United Kingdom
  • December 6 2016

The Court of Appeal recently handed down a Decision in Napp Pharmaceutical Holdings Limited v Dr Reddy’s Laboratories (UK) Limited and Sandoz Limited


When Relying upon Scientific Test Data in its Petition, the Petitioner Must Provide Sufficient Information to Permit the PTAB to Evaluate the Data and its Reliability
  • Jones Day
  • USA
  • December 6 2016

On November 14, 2016, the PTAB issued a Final Written Decision upholding Paragon Bioteck, Inc.’s patent, U.S. Patent No. 8,859,623 B1 (the “’623


The Patient Side of the CRISPR Patent Battle
  • Dilworth IP
  • USA
  • December 6 2016

A contentious patent battle has continued to rage between the Broad Institute at HarvardMIT and the University of California (UC). UC is challenging